TIGIT and neoplasm: In their study, the proportions of TIGIT+CD3+, TIGIT+CD4+, and TIGIT+CD8+ T cells in the peripheral blood of CRC patients were higher than in healthy donors, and these subsets were even more enriched in tumor tissue than in matched blood samples.